Kestra Advisory Services’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8,403
| Closed | -$201K | – | 2107 |
|
|
2023
Q2 | $201K | Buy |
+8,403
| New | +$201K | ﹤0.01% | 1904 |
|
|
2022
Q2 | – | Sell |
-8,596
| Closed | -$208K | – | 2130 |
|
|
2022
Q1 | $208K | Buy |
+8,596
| New | +$208K | ﹤0.01% | 1825 |
|
|
2021
Q4 | – | Sell |
-10,438
| Closed | -$173K | – | 2006 |
|
|
2021
Q3 | $173K | Sell |
10,438
-152
| -1% | -$2.52K | ﹤0.01% | 1994 |
|
|
2021
Q2 | $258K | Sell |
10,590
-1,071
| -9% | -$26.1K | ﹤0.01% | 1670 |
|
|
2021
Q1 | $301K | Sell |
11,661
-3,942
| -25% | -$102K | ﹤0.01% | 1465 |
|
|
2020
Q4 | $838K | Buy |
15,603
+2,753
| +21% | +$148K | 0.01% | 941 |
|
|
2020
Q3 | $530K | Buy |
+12,850
| New | +$530K | 0.01% | 858 |
|